✦ LIBER ✦

Amoxicillin/Clavulanic Acid 2000mg/125mg Extended Release (XR)

✍ Scribed by Paul L. McCormack, Gillian M. Keating

Book ID: 119928279
Publisher: Springer International Publishing AG
Year: 2005
Tongue: English
Weight: 269 KB
Volume: 65
Category: Article
ISSN: 0012-6667
DOI: 10.2165/00003495-200565010-00014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Spotlight on Amoxicillin/Clavulanic Acid

Spotlight on Amoxicillin/Clavulanic Acid 2000mg/125mg Extended Release (XR) in Respiratory Tract Infections in Adults

✍ Paul L. McCormack, Gillian M. Keating 📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 70 KB

Comparative Bioavailability of Two Oral

Comparative Bioavailability of Two Oral 875/125mg Sachet Formulations of Amoxicillin/Clavulanic Acid in Healthy Volunteers

✍ M. A. Gálvez-Múgica, J. Frías-Iniesta, P. Guerra, A. J. Carcas, A. Fernandez-Aij 📂 Article 📅 1999 🏛 Springer International Publishing AG 🌐 English ⚖ 188 KB

Comparative in vitro activity of a pharm

Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000

✍ Laura M. Koeth; Michael R. Jacobs; Caryn E. Good; Saralee Bajaksouzian; Anne Win 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Efficacy of amoxicillin/clavulanic acid

Efficacy of amoxicillin/clavulanic acid 2000/125 mg in preventing infection after extraction of impacted mandibular third molar totally covered by bone: preliminary results

✍ M. Arteagoitia; G. Santamaria; E. Ramos; L. Barbier; J. Alvarez; J. Martín; J. B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Bioequivalence evaluation of two brands

Bioequivalence evaluation of two brands of amoxicillin/clavulanic acid 250/125 mg combination tablets in healthy human volunteers: Use of replicate design approach

✍ Nasir M. Idkaidek; Ahmad Al-Ghazawi; Naji M. Najib 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

## Abstract The purpose of this study was to apply a replicate design approach to a bioequivalence study of amoxicillin/clavulanic acid combination following a 250/125 mg oral dose to 23 subjects, and to compare the analysis of individual bioequivalence with average bioequivalence. This was conduct

Efficacy of a new pharmacokinetically en

Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains

✍ Thomas M. File; Javier Garau; Michael R. Jacobs; Brian Wynne; Monique Twynholm; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 176 KB